http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-347388-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-06
filingDate 1995-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7292f0c9ba051d5bd28b0a066fd7b53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_203fd1ad94f3e233b1534bcbdd79f27e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9763ffacf1b696c2deb2ba83d0e75d6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd0a1ae168912527bad4afa1ca866375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21902c33db7fa8cd6478abc6a5d2c9d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87c24fa10df368a3a4cc6b2d4a1e5fa8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_044882903becf445281c581b82f58aa2
publicationDate 1998-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-347388-B
titleOfInvention Oxazolidinone derivatives having adhesion receptor antagonism
abstract An oxazolidinone derivative of the formula I (I) in which R1 is (group); R2 is H, A, Ac, A-SO2-, Ar-SO2- or a known amino protective group; R3 is H or A, A being a C1-C6-alkyl; D is H2N-C(=NH)- where the primary group also can provide a known amino protective group; Ac is C1-C10-alkanoyl or C7-C11-aroyl; Ar is phenyl which is unsubstituted or mono-substituted by A, or benzyl; and physiologically unobjectionable salts thereof.
priorityDate 1994-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73949

Total number of triples: 31.